15
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Investigation of Ornithine Decarboxylase Activity and Two-Dimensional Electrophoretic Protein Profile Following Exposure of T24 Bladder Carcinoma Cells to Tumor Promoter and Carcinogen

Pages 27-41 | Published online: 30 Sep 2008

REFERENCES

  • American Cancer Society. Cancer Facts and Figures—1995. Atlanta, GA, 95-375M-No5008.95; 1995.
  • Silverberg E, Boring C, Squires TS. Cancer statistics 1990. CA. 1990; 40:9–26.
  • Gordon GB, Helzlouer KJ, Comstock GW. Serum levels of dehydroepiandrosterone and its sulfate and the risk of developing bladder cancer. Cancer Res. 1991; 51:1366- 1369.
  • Rubben H, Lutzeyer W, Wallace DMA, Zingg EJ, Wallace DM,The epidemiology and aetiology of bladder cancer eds. Bladder Cancer, Clinical Practice in Urology Series. New York: Springer; 1985:1–27.
  • Sporn MB. Carcinogenesis and cancer: different perspectives on the same disease. Cancer Res. 1991; 51:6215–6218.
  • Perera FP. Molecular cancer epidemiology: a new tool in cancer prevention. J Natl Cancer Inst. 1987;78:887–898.
  • Singh J, Kelloff G, Reddy BS. Effect of chemopreventive agents on intermediate biomarkers during different stages of azoxymethane-induced colon carcinogenesis. Cancer Epidem. Biomarkers Prevention. 1992;1:405–411.
  • Hsieh JT, Verma AK. Involvement of protein kinase C in the transcriptional regulation of ornithine decarboxylase gene expression by 12-o-tetradecanoylphorbol-13-acetate in T24 human bladder carcinoma cells. Arch Biochem Biophys. 1988;262:326–336.
  • Russell DH. Ornithine decarboxylase: A key regulatory enzyme in normal and neoplastic growth. Drug Metabolic Rev. 1985;16:1–88.
  • Anderson G, Heby O. Polyamine and nucleic acid concentrations in Ehrlich ascites carcinoma cells and liver of tumor bearing mice at various stages of tumor growth. J Natl Cancer Inst. 1972; 48:165–172.
  • O'Brian TG. The induction of ornithine decarboxylase as an early possibly obligatory event in mouse skin carcinogenesis. Cancer Res. 1976;36:2644–2653.
  • Luk GD, Hamilton SR, Yang P, et al. Kinetic changes in mucosal ornithine decarboxylase activity during azoxymethane-induced colonic carcinogenesis in the rat. Cancer Res. 1986;46:4449–4452.
  • Kingsworth AN, King WWK, Diekema KA, McCann PP, Ross JS, Malt RA. Inhibition of ornithine decarboxylase with 2-difluoromethylornithine: reduced incidence of dimethylhydrazine induced colon tumor in mice. Cancer Res. 1983;43:2545–2549.
  • Gilmour SK, Verma AK, Madara T, O'Brien TG. Regulation of ornithine decarboxylase gene expression in mouse epidermis and epidermal tumors during two-stage tumorigenesis. Cancer Res. 1987; 47:1221–1225.
  • Claverie N, Mamont PS. Comparative antitumor properties in rodents of irreversible inhibitors of l- ornithine decarboxylase, used as such or as prodrugs. Cancer Res. 1989;49:4466–4471.
  • Homma Y, Kakizoe T, Samma S, Oyasu R. Inhibition of n-butyl -n-(4-hydroxybutyl) nitrosamine- induced rat urinary bladder carcinogenesis by a-difluoromethylornithine. Cancer Res. 1987;47:6176–6179.
  • Ross RK, Paganini-Hill A, Henderson BE. Epidemiology of bladder cancer. In: Skinner D, Lieskovsky G, eds. Diagnosis and Management of Genitourinary Cancer. Philadelphia, PA: Saunders; 1988:2331.
  • Case RAM, Hosker ME, McDonald DB, Pearson JT. Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry, 1: the role of aniline, benzidine, alpha-naphthylamine, and beta-naphthylamine. Br J Ind Med. 1954; 11:75–104.
  • Melick WF, Naryka JJ, Kelly RE. Bladder cancer due to exposure to para-aminobiphenyl: a 17-year followup. J Urol. 1971; 106:220–226.
  • Haugen DA, Peak MJ, Suhbler KM, Stamoudis VC. Isolation of mutagenic amines from a coal conversion oil by cation exchange chromatography. Anal Chem. 1982;54:32–37.
  • Talaska G, Al-Juburi AZSS, Kadlubar FF. Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8- yl) 4-aminobipheny l as a major adduct. Proc Natl Acad Sci. 1991;88:5350–5354.
  • Kuller LH, Garfinkel L, Correa P, et al. Contribution of passive smoking to respiratory cancer. Environ Health Perspect. 1986;70:57–69.
  • Seidel ER. Hormonal regulation of postprandial induction of gastrointestinal ornithine decarboxylase activity. Am J Physiol. 1986;251:460–466.
  • Bachrach U. The induction of ornithine decarboxylase in normal and neoplastic cells. In: Gaugus JM, ed. Polyamines in Biomedical Research. New York: Wiley; 1980:81–107.
  • Nicolson GL. Gene expression, cellular diversification and tumor progression to the metastatic pheno- type. BioEssays. 1991;13:337–342.
  • Bubenick J, Baresova M, Vicklicky V, Jakoubkova J, Sainerova H, Donner J. Established cell line of urinary bladder carcinoma (T24) containing tumour specific antigen. Int J Cancer. 1973; 11:765–773.
  • Anderson NL. Two-Dimensional Electrophoresis: Operation of the ISO-DALT System. Washington, DC: Large Scale Biology; 1988.
  • Pegg AE. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res. 1988;44:4924–4928.
  • Nishioka K, Grossie VB, Chang TH, Ajani JA, Ota DM. Colorectal ornithine decarboxylase activity in human mucosa and tumors: elevation of enzymatic activity in distal mucosa. J Surg Oncol. 1991;47:117–120.
  • Moorhead RJ, Hoper M, McKelvey STD. Assessment of ODC activity in rectal mucosa as a marker for colorectal adenomas and carcinomas. Br J Surg. 1987; 74:364–365.
  • Love RR, Surawicz TS, Morrisey JF, Verma AK. Levels of colorectal ornithine decarboxylase activity in patients with colon cancer, a family history of nonpolypos is hereditary colonic cancer, a family history of nonpolypos is hereditary colonic cancer and adenomas. Cancer Epidemiol Biomarkers Prev. 1992; 1:195–198.
  • Miller MJ, Schwartz DM, Thorgeirsson SS. Inter- and intraclonal variability of polypeptides synthesized in a rat hepatoma cell line: quantitative two-dimensional gel analysis. J Biol Chem. 1988; 263:1122711236.
  • Hemstreet GP, Rao JY, Hurst RE, et al. Intermediate endpoint biomarkers for chemoprevention. J Cell Bio chem Suppl. 1992;161:93–110.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.